, Bilans annuels. Les infections invasives à méningocoques en, 2015.
, French Ministry of Social Affairs and Health. Instruction DGS/ RI1/DUS/2014/301 du 24 octobre 2014 relative à la prophylaxie des infections invasives à méningocoque. [National recommendations and policy regarding prophylaxis of invasive meningococcal diseases
, , 2014.
,
Outbreak of group B meningococcal disease in France prompted community chemoprophylaxis, Euro Surveill, vol.4, issue.13, p.1631, 2000. ,
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect Dis, vol.11, issue.6, pp.455-63, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02083160
Community outbreak of group B meningococcal disease in southwest France, Euro Surveill, vol.15, issue.37, p.20929645, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02082943
Calendrier des vaccinations et recommandations vaccinales 2016. [Vaccination schedule and vaccine recommendations, vol.20, 2016. ,
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc Natl Acad Sci USA, vol.95, issue.6, p.9501229, 1998. ,
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.5, p.23414709, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02093031
Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine, Hum Vaccin Immunother, vol.13, issue.3, p.27808594, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01579663
Characteristics and changes in invasive meningococcal disease epidemiology in France, J Infect, vol.74, issue.6, p.28279715, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013252
Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study, Lancet Infect Dis, vol.15, issue.12, pp.1420-1428, 2015. ,
Avis relatif à l'utilisation du vaccin Bexsero ,
Haut conseil de la santé Publique, vol.25, 2013. ,
Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease, Vaccine, vol.34, issue.7, p.26686570, 2016. ,
Estimation des couvertures vaccinales à partir des données de l'Assurance maladie. Exemple de la vaccination contre le meningocoque C ,
, , 2015.
, Analysis of vaccine coverage during a preventive vaccination campaign against meningococcus C, 2002.
, Etude de la couverture vaccinale suite à la campagne de vaccination contre le méningocoque C dans les Landes, les Pyrénées Atlantiques et les Hautes Pyrénées en, 2002.
Évaluation des couvertures vaccinales et des campagnes de vaccination contre le méningocoque C dans la vallée de Barcelonnette, Alpes de Haute-Provence, janvier-février 2007. [Evaluation of the vaccination coverage and the vaccination campaigns against meningococcus C in, 2007. ,